drug resistance via HOXA9 in colorectal carcinoma cells
It is demonstrated that NAC1 may be a critical factor in the development of chemoresistance, offering a potential novel target for the treatment of CRC.
Tong-Fa Ju, Huicheng Jin, Rongchao Ying et al.
· 0 citations